Seeing Is Believing
Currently out of the existing stock ratings of Paola Sabbione, 13 are a BUY (86.67%), 2 are a HOLD (13.33%).
Analyst Paola Sabbione, currently employed at BARCLAYS, carries an average stock price target met ratio of 50% that have a potential upside of 23.89% achieved within 593 days.
Paola Sabbione’s has documented 30 price targets and ratings displayed on 5 stocks. The coverage is on Industrials, Healthcare, Technology sectors.
Most recent stock forecast was given on FC, Franklin Covey Company at 02-Feb-2023.
Analyst best performing recommendations are on MD (MEDNAX).
The best stock recommendation documented was for MD (MEDNAX) at 7/21/2022. The price target of $9.14 was fulfilled within 483 days with a profit of $14.26 (60.94%) receiving and performance score of 1.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
What Year was the first public recommendation made by Paola Sabbione?